Home' NZMJ Digest : NZMJ Digest Issue 61 Contents 17
Even when under supervision, junior doctors are responsible for
treatment they provide and must provide care of an appropriate
standard and discharge their duties under Right 4 of the Code. So too
the supervising doctor. Where either fail to provide treatment of an
appropriate standard, they run the risk of being held to have breached
Although junior doctors are to a large degree protected from
responsibility by calling for help, doing so does not provide them with
an immunity. They must speak up when something seems wrong.
Likewise, supervising doctors must provide adequate supervision, and
should only delegate tasks they have good reason to believe a junior
doctor is competent to perform. The standard to be applied in judging
the adequacy of supervision is objective: the level of expertise and
experience of the senior doctor in supervising doctors is not relevant,
but the level of expertise and experience of the junior doctor is relevant.
1. Craig T Hore, William Lancashire and Robert G Fassett “Clinical supervision by
consultants in teaching hospitals” Med J Aust 2009; 191 (4):220-222 .
2. Rudland et al “Special series: Maximising learning through effective
supervision” NZMJ 123 (1309), 19 February 2010.
3. Joanna Manning “The required standard of care for treatment” in Skegg and
Paterson (eds) Health Law in New Zealand (Thomson Reuters, Wellington,
2015) at 114-115.
4. Manning, at 115.
5. Manning, at 116.
6. Manning, at 116-117.
7. Manning, at 117.
8. Ron Paterson “Supervisory responsibilities of specialists” 16 February 2001
(available online at: www.hdc.org.nz/education/presentations/supervisory-
9. See generally, Medical Practitioners Disciplinary Tribunal, decision
177/01/77D (2001); HDC opinions 98HDC15093 (1999), 98HDC15902 (2000),
The Pharmacology and Therapeutics
Advisory Committee (PTAC) Membership
PHARMAC is the Government agency responsible for ensuring New Zealanders have access to
a wide range of affordable medicines. PHARMAC makes a vital contribution to New Zealand’s
The Pharmacology and Therapeutics Advisory Committee (PTAC) is an advisory committee
to PHARMAC. It is made up of vocationally registered health practitioners with exper tise in
critical appraisal in fields such as clinical pharmacology, internal medicine and general practice.
PTAC’s role, defined in legislation, is to provide PHARMAC’s Board with objective advice on
pharmaceuticals, including devices, and their benefits.
PTAC considers and makes recommendations on proposed amendments to the Pharmaceutical
Schedule, whether related to funding new pharmaceuticals or changing funding criteria for
pharmaceuticals already funded.
PTAC members are appointed by the Director-General of Health, in consultation with the
The Director-General is seeking applications from suitably qualified and experienced clinicians to
be appointed to the Pharmacology and Therapeutics Advisor y Committee (PTAC).
PTAC meets in Wellington at least four times a year. To be on PTAC, you should be in active clinical
practice and have:
• excellent critical appraisal skills;
• a good general knowledge of medicine and pharmaceuticals;
• at least five years’ experience in your vocational field;
• the ability to differentiate between an individual and societal perspective on issues;
• a good understanding of evidence-based medicine in clinical practice.
We are seeking applications from health practitioners with a good understanding of cancer
medicine; however we would consider other applicants.
PTAC’s Terms of Reference, Appointment Process and position description for this role are
available on the PHARMAC website http://www.pharmac.govt.nz/about/committees/ptac/
For further information on this role, please contact:
Dr John Wyeth, Medical Director via email john.w firstname.lastname@example.org
How to Apply
For your application to be accepted, please send your current
CV along with a cover letter to email@example.com with
‘PTAC Member’ and your name in the subject line. We would like
to hear about your experience, background and what appeals to
you in this role. Please advise your availability to start. Interviews
will be scheduled during August and September 2016.
We encourage you to apply now, and no later than Sunday,
31 July 2016.
Links Archive NZMJ Digest Issue 60 NZMJ Digest Issue 62 Navigation Previous Page Next Page